When were recommendations for the management of primary cutaneous CD30+LPDs of non-Hodgkin lymphoma (NHL) issued?

Updated: Jun 12, 2019
  • Author: Priyank P Patel, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Answer

In 2011, the the European Organization for Research and Treatment of Cancer (EORTC), the International Society for Cutaneous Lymphoma (ISCL), and the US Cutaneous Lymphoma Consortium (USCLC) published joint consensus recommendations for the management of primary cutaneous CD30+ T-Cell lymphoproliferative disorders (CD30+LPDs). [30]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!